Article Text
Abstract
Drug-induced haemolytic anaemia (DIHA) is a rare and potentially life-threatening condition associated with various medications, including cephalosporins. DIHA can be either immune-mediated or non-immune-mediated, distinguishable through direct antiglobulin testing, also known as Coombs testing. Cephalexin has been implicated in both forms. Non-immune DIHA likely results from direct drug toxicity to erythrocytes, whereas immune-mediated DIHA, a type II hypersensitivity reaction, involves drug-dependent antibodies and/or autoantibodies and is often triggered by penicillins, cephalosporins and non-steroidal anti-inflammatory drugs. We present a case of a woman in her late fifties who developed acute renal failure necessitating emergent haemodialysis following a single dose of cephalexin. She was subsequently diagnosed with cephalexin-induced autoimmune haemolytic anaemia. This case illustrates the importance of considering DIHA in patients presenting with renal failure and haemolytic anaemia.
- Renal system
- Haematology (incl blood transfusion)
- Unwanted effects / adverse reactions
- Dialysis
Statistics from Altmetric.com
Footnotes
Contributors PM is the guarantor. PM participated in writing the material and appreciated additional writing, edits and suggestions from JM, SK, SW and AC.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.